.png){kind=icon}
返回
Systemic sclerosis
.png){kind=icon}
OA
AI
DOI：10.1016/S0140-6736(22)01692-0.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Systemic sclerosis, also known as scleroderma, is a rare and complex autoimmune connective-tissue disease. Once considered an untreatable and unpredictable condition, research advancements have improved our understanding of its disease pathogenesis and clinical phenotypes and expanded our treatment armamentarium. Early and accurate diagnosis is essential, while ongoing efforts to risk stratify patients have a central role in predicting both organ involvement and disease progression. A holistic approach is required when choosing the optimal therapeutic strategy, balancing the side-effect profile with efficacy and tailoring the treatment according to the goals of care of the patient. This Seminar reviews the multiple clinical dimensions of systemic sclerosis, beginning at a precursor very early stage of disease, with a focus on timely early detection of organ involvement. This Seminar also summarises management considerations according to the pathological hallmarks of systemic sclerosis (eg, inflammation, fibrosis, and vasculopathy) and highlights unmet needs and opportunities for future research and discovery.
Keyword:
PULMONARY-ARTERIAL-HYPERTENSION
INTERSTITIAL LUNG-DISEASE
STEM-CELL TRANSPLANTATION
CONTINUOUS INTRAVENOUS EPOPROSTENOL
SCLERODERMA RENAL CRISIS
DOUBLE-BLIND
CONNECTIVE-TISSUE
MYCOPHENOLATE-MOFETIL
PROSTACYCLIN ANALOG
SKIN THICKNESS
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
88.5
论文数:
5.4W
被引数:
34.8W
机构
引用论文
.png){kind=icon}
分享收藏
A review of morphology–elasticity relationships in human trabecular bone: theories and experiments
PREAI
分享收藏
查看更多内容